# OnCo record nct00295763 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00295763/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00295763", "NCT00295763" ;
  schema:name "A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen"@en ;
  schema:description "A phase 3 trial of Thyrotropin alfa in Thyroid cancer, run by Genzyme, a Sanofi Company, completed."@en ;
  schema:url <https://onco.cc/trials/nct00295763/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00295763> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:drugs <https://onco.cc/drugs/thyrotropin-alfa/> ;
  onco:companies <https://onco.cc/companies/sanofi/> .